Literature DB >> 10489992

Controls who experienced hypothetical causal intermediates should not be excluded from case-control studies.

C Poole1.   

Abstract

It has been suggested that controls with adenomatous polyps of the colon and rectum should be excluded from case-control studies of cigarette smoking and colorectal cancer. A claim has been made that the presence of such controls creates a bias toward the null. The polyps are an intermediate step in a hypothetical causal pathway between the exposure and the disease. Thus, the recommendation logically extends to the exclusion of all controls who experienced hypothetical causal intermediates from all case-control studies. It is shown, in the simple case of an exposure that acts solely through the pathway involving the intermediate, that such exclusions create a bias away from the null. The rationale for recommending the detrimental exclusions appears to stem from a variant of the "trohoc fallacy": the mistaken view of case-control studies as comparisons between diseased and healthy groups and not as comparisons between groups that differ by exposure.

Entities:  

Mesh:

Year:  1999        PMID: 10489992     DOI: 10.1093/oxfordjournals.aje.a010051

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

Review 1.  Design issues for drug epidemiology.

Authors:  A D McMahon; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

2.  Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study.

Authors:  Gary D Slade; Eric Bair; Kunthel By; Flora Mulkey; Cristina Baraian; Rebecca Rothwell; Maria Reynolds; Vanessa Miller; Yoly Gonzalez; Sharon Gordon; Margarete Ribeiro-Dasilva; Pei Feng Lim; Joel D Greenspan; Ron Dubner; Roger B Fillingim; Luda Diatchenko; William Maixner; Dawn Dampier; Charles Knott; Richard Ohrbach
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

3.  Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Richard Ohrbach; Roger B Fillingim; Flora Mulkey; Yoly Gonzalez; Sharon Gordon; Henry Gremillion; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Joel D Greenspan; Charles Knott; William Maixner; Gary Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

4.  Acute alcohol consumption, alcohol outlets, and gun suicide.

Authors:  Charles C Branas; Therese S Richmond; Thomas R Ten Have; Douglas J Wiebe
Journal:  Subst Use Misuse       Date:  2011-09-19       Impact factor: 2.164

5.  Precursors in cancer epidemiology: aligning definition and function.

Authors:  Sholom Wacholder
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

6.  Cholecystectomy and the risk of colorectal adenomas.

Authors:  Lisa C Vinikoor; Joseph A Galanko; Robert S Sandler
Journal:  Dig Dis Sci       Date:  2007-08-21       Impact factor: 3.199

7.  Investigating the link between gun possession and gun assault.

Authors:  Charles C Branas; Therese S Richmond; Dennis P Culhane; Thomas R Ten Have; Douglas J Wiebe
Journal:  Am J Public Health       Date:  2009-09-17       Impact factor: 9.308

8.  Alcohol consumption, alcohol outlets, and the risk of being assaulted with a gun.

Authors:  Charles C Branas; Michael R Elliott; Therese S Richmond; Dennis P Culhane; Douglas J Wiebe
Journal:  Alcohol Clin Exp Res       Date:  2009-03-11       Impact factor: 3.455

9.  The Influence of Screening for Precancerous Lesions on Family-Based Genetic Association Tests: An Example of Colorectal Polyps and Cancer.

Authors:  Stephanie L Schmit; Jane C Figueiredo; Victoria K Cortessis; Duncan C Thomas
Journal:  Am J Epidemiol       Date:  2015-08-24       Impact factor: 4.897

10.  Metabolomics to reveal biomarkers and pathways of preterm birth: a systematic review and epidemiologic perspective.

Authors:  R A Carter; K Pan; E W Harville; S McRitchie; S Sumner
Journal:  Metabolomics       Date:  2019-09-10       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.